All Topics
All Topics
Technology
Technology
Design
Design
Programming
Programming
Science
Science
News
News
Gaming
Gaming
Entertainment
Entertainment
Business
Business
Finance
Finance
Sports
Sports
Health
Health
Food
Food
Travel
Travel
Art
Art
Music
Music
Books
Books
Education
Education
Politics
Politics
Personal
Personal
No algorithm. No AI slop. No ads. Just RSS. Pro-human. Indie writers. Real journalism. Open web. Chronological. Hand toasted.

First Successful In-Utero Stem Cell Therapy for Spina Bifida Shows Safety in Phase 1 Trial

By

gmays

3mo ago· 4 min readenNews

Summary

UC Davis Health researchers have successfully performed the world's first in-utero stem cell therapy for spina bifida repair, combining fetal surgery with human placenta-derived stem cells. The Phase 1 clinical trial results published in The Lancet demonstrate the treatment is safe and feasible, marking a significant advancement in prenatal medicine for this congenital condition where the spinal cord fails to close properly during fetal development.

Key quotes

· 4 pulled
UC Davis Health research team has safely performed the world's first spina bifida treatment combining fetal surgery with stem cells
The study tested whether adding a layer of human placenta-derived stem cells to standard fetal surgery could be done safely
Spina bifida, also known as myelomeningocele, occurs when the spinal cord fails to close properly during fetal development
These results have been published today in The Lancet
Snippet from the RSS feed
A UC Davis Health research team has safely performed the world’s first spina bifida treatment combining fetal surgery with stem cells, according to results from Phase 1 of an ongoing clinical trial. These results have been published today in The Lan

You might also wanna read

Experimental pill daraxonrasib extends survival in advanced pancreatic cancer patients, study finds

Researchers reported that daraxonrasib, a novel experimental pill, helped patients with advanced pancreatic cancer live longer by blocking a

npr.org·4h ago

GeneSkin Develops mRNA Therapy Targeting Skin Stem Cells for Rejuvenation and Hair Growth

GeneSkin is developing a novel mRNA therapy targeting basal stem cells in the skin to address a wide range of dermatological issues includin

wyss.harvard.edu·6h ago

First human trial begins for drug that could regrow missing teeth

Kyoto University Hospital has launched the first human trial of TRG-035, a drug designed to regrow teeth in adults by blocking a protein tha

boingboing.net·1d ago

Japanese researchers develop vitamin K-like compounds that may help convert brain cells into neurons

Japanese researchers have developed a new family of vitamin K-like molecules that may help immature brain cells transition into neurons. Whi

zmescience.com·1d ago

International trial shows DNA test could help many breast cancer patients avoid chemotherapy

A new international trial presented at the American Society of Clinical Oncology conference suggests that millions of breast cancer patients

bbc.co.uk·1d ago

Cohort Study Evaluates Age at Onset and Family History as Predictors for Genetic Testing in Parkinson Disease

This cohort study evaluates the association between age at onset (AAO) and family history in Parkinson disease patients who carry pathogenic

doi.org·1d ago